Global Bio-chem Technology Group Co. Ltd. (HK:0809)
:0809
Want to see HK:0809 full AI Analyst Report?
0809 Stock Chart & Stats
HK$0.06
>-HK$0.01(-1.00%)
At close: 4:00 PM EST
HK$0.06
>-HK$0.01(-1.00%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.12
Previous CloseN/A
Volume370.00K
Average Volume (3M)8.43M
Market Cap
HK$990.50M
Enterprise ValueHK$2.23B
Total Cash (Recent Filing)HK$94.44M
Total Debt (Recent Filing)HK$1.79B
Price to Earnings (P/E)17.3
Beta-0.15
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding16,832,771,000
10 Day Avg. Volume3,078,640
30 Day Avg. Volume8,433,551
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-3.27
Price to Sales (P/S)0.74
P/FCF Ratio-59.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Corn-based Product PortfolioA broad product mix across animal nutrition, food and industrial end-markets provides structural demand diversification. Staples like lysine support recurring volumes from feed producers, helping sustain base revenue and reduce exposure to a single end-market over a multi-month horizon.
Historical Revenue Expansion CapabilityReported multi-period revenue growth near mid-teens shows the company has demonstrated commercial traction and the ability to scale sales. Even with volatility, an underlying capacity to grow revenue supports medium-term recovery if cost and utilization dynamics improve.
Periodic Free Cash Flow GenerationIntermittent periods of strong free cash flow indicate the business can generate internal funding when operations or pricing align. This episodic cash conversion points to latent cash-generation potential that can be harnessed if margins and working capital stabilize.
Bears Say
Negative Shareholders' Equity And High LeveragePersistent negative equity and material debt create a structurally weak balance sheet, constraining financing options and strategic flexibility. High leverage increases refinancing and solvency risk, limiting the firm's ability to invest in capacity or weather prolonged industry stress.
Weak And Inconsistent Cash GenerationRecent negative operating and free cash flow undermine the company's ability to service debt, fund capex or rebuild liquidity. Cash generation volatility reduces resilience to commodity and demand swings and raises the probability of disruptive financing or asset sales in the medium term.
Thin Margins And Persistent Negative EBITLow gross margins and repeated negative operating income indicate weak pricing power or high input costs. Structural margin pressure limits operating leverage, making sustained profitability and internal cash generation difficult without cost reduction or product mix improvement.
Global Bio-chem Technology Group Co. Ltd. News
0809 FAQ
What was Global Bio-chem Technology Group Co. Ltd.’s price range in the past 12 months?
Global Bio-chem Technology Group Co. Ltd. lowest stock price was HK$0.06 and its highest was HK$0.12 in the past 12 months.
What is Global Bio-chem Technology Group Co. Ltd.’s market cap?
Global Bio-chem Technology Group Co. Ltd.’s market cap is HK$990.50M.
When is Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date?
Global Bio-chem Technology Group Co. Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 73 days.
How were Global Bio-chem Technology Group Co. Ltd.’s earnings last quarter?
Global Bio-chem Technology Group Co. Ltd. released its earnings results on Mar 27, 2026. The company reported HK$0.032 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.032.
Is Global Bio-chem Technology Group Co. Ltd. overvalued?
According to Wall Street analysts Global Bio-chem Technology Group Co. Ltd.’s price is currently Overvalued.
Does Global Bio-chem Technology Group Co. Ltd. pay dividends?
Global Bio-chem Technology Group Co. Ltd. pays a Semiannually dividend of HK$0.02 which represents an annual dividend yield of N/A. See more information on Global Bio-chem Technology Group Co. Ltd. dividends here
What is Global Bio-chem Technology Group Co. Ltd.’s EPS estimate?
Global Bio-chem Technology Group Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Bio-chem Technology Group Co. Ltd. have?
Global Bio-chem Technology Group Co. Ltd. has 16,832,771,000 shares outstanding.
What happened to Global Bio-chem Technology Group Co. Ltd.’s price movement after its last earnings report?
Global Bio-chem Technology Group Co. Ltd. reported an EPS of HK$0.032 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.667%.
Which hedge fund is a major shareholder of Global Bio-chem Technology Group Co. Ltd.?
Currently, no hedge funds are holding shares in HK:0809
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Global Bio-chem Technology Group Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.23%
12-Months-Change
Fundamentals
Return on Equity
-11.47%
Trailing 12-Months
Asset Growth
1.69%
Trailing 12-Months
Company Description
Global Bio-chem Technology Group Co. Ltd.
Global Bio-chem Technology Group Company Limited, an investment holding enterprise, is engaged in the global production and distribution of both refined corn products and biochemicals derived from corn. Its market reach extends across the People's Republic of China, other Asian countries, the Americas, and international territories. The group's operations are divided into four main divisions: Upstream Products, Amino Acids, Corn Sweeteners, and Polyol Chemicals. The company's diverse product portfolio includes a range of corn-refined items such as corn oil, corn steep liquor, corn starch, waxy corn starch, corn gluten meal, feed pellets, and corn germ cake. Furthermore, it offers a variety of downstream corn-based biochemicals, encompassing amino acids like lysine, protein lysine, threonine, and glutamic acid. Its corn sweeteners segment includes high fructose corn syrup, maltodextrin, high maltose syrup, maltose syrup, sorbitol, glucose, and crystallized glucose. Additionally, the firm manufactures modified starches and various chemicals, such as ethylene, propylene, butylene glycols, and resins. Complementing these, the company also supplies anti-freeze solutions, hydrogen, and ammonia. These products serve a multitude of applications across numerous industries, including animal feed manufacturing, food and beverage production, cosmetics, textiles, pharmaceuticals, and the broader chemical sector. Established in 1994, the company's headquarters are situated in Hung Hom, Hong Kong.
Technical Analysis
Global Sweeteners Holdings Limited
―
Natural Food International Holding Ltd.
―
Vedan International (Holdings) Ltd.
―
China Starch Holdings Limited
―
Asia Cassava Resources Holdings Limited
―
Options Prices
Currently, No data available
---